Patent · US Active

Substituted pyrazines for use in the treatment of inflammatory or allergic conditions

US7803804B2 · kind B2 · utility

6Cited by

0References

3Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Stephen Paul Collingwood · Westhoughton, GB
Nichola Smith · Horsham, GB

Key dates

Filing date	Dec 20, 2006
Grant date	Sep 28, 2010
Priority date	—
Expiry date	Dec 20, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are substituted pyrazine compounds and tautomers, stereoisomers, solvates, or pharmaceutically acceptable salts thereof for the treatment of conditions mediated by the blockade of an epithelial sodium channel, particularly an inflammatory or allergic condition, including compounds of formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.